Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Feb 7:8:1-5.
doi: 10.2174/1874285801408010001. eCollection 2013.

A retrospective analysis of isoniazid-monoresistant tuberculosis: among Iranian pulmonary tuberculosis patients

Affiliations

A retrospective analysis of isoniazid-monoresistant tuberculosis: among Iranian pulmonary tuberculosis patients

Mohammad Varahram et al. Open Microbiol J. .

Abstract

Background and objectives: Isoniazid (INH) is one of the most potent anti-tuberculosis (TB) drugs. The spread and transmission of INH- resistant bacilli are likely to pose a significant problem for National TB control Program (NTP). In this study, we aimed to determine the trend of INH-monoresistant TB in Iran.

Methods: The susceptibility patterns of Mycobacterium tuberculosis (MTB) strains that were isolated from clinical samples were retrospectively analyzed (January 2003-December 2011). Identification and drug susceptibility testing (DST) were performed using both conventional and molecular methods. The associated risk factors were assessed using the Chi-square test.

Results: Out of 4825 culture-positive isolates, 6.1% were resistant to INH, with an increasing trend over the study period. The INH-monoresistance from 4.4 in 2003 reached to 9.4% in 2011. Among the studied risk factors, age was significantly associated with INH-monoresistance (p < 0.05).

Conclusions: The increased trend in INH-monoresistance underlines the need for greater enforcement of national TB control programs. In this regard, better management of TB cases, establishing advanced diagnostic facilities and use of standard treatment regimens are recommended to avoid further emergence of INH resistant cases.

Keywords: Drug resistance; Iran; Mycobacterium tuberculosis.; isoniazid.

PubMed Disclaimer

Figures

Fig. (1)
Fig. (1)
Isoniazid-monoresistant TB in Iran, 2003 to 2011.

References

    1. World Health Organization (WHO). Global Health Observatory Data Repository 2013. Available from: http://appswho int/ghodata. 2013
    1. Masjedi MR, Farnia P, Sorooch S , et al. Extensively drug-resistant tuberculosis: 2 years of surveillance in Iran. Clin Infect Dis. 2006;43:841–7. - PubMed
    1. Velayati AA, Masjedi MR, Farnia P , et al. Emergence of new forms of totally drug-resistant tuberculosis bacillisuper extensively drug-resistant tuberculosis or totally drug-resistant strains in Iran. Chest J. 2009;136:420–5. - PubMed
    1. Velayati AA, Farnia P, Masjedi MR. Totally drug-resistant tuberculosis (TDR-TB): A debate on global health communities. Int J Mycobacteriol. 2013 - PubMed
    1. Velayati AA, Farnia P, Masjedi MR. Letter to Editor The totally drug resistant tuberculosis (TDR-TB). Int J Clin Exp Med. 2013;6:307–09. - PMC - PubMed

LinkOut - more resources